Docket #: S17-163
Phase-change nanoparticles for neuromodulation
Stanford researchers at the Airan Lab have developed a new method for robust and spatiotemporally precise non-invasive neuromodulation that could transform both basic and clinical neuroscience.
This technology focally releases drugs from nanoparticles within the brain and peripheral nervous system with the application of focused ultrasound. The system can encapsulate and deliver most any small molecule drug, especially lipophilic drugs that would normally cross the blood- brain barrier. This system is effective and safe. In addition, the particles can be produced in large scales with cGMP-compatible methods.
Figure
Stage of Research
Applications
- Pre-surgical mapping of functional brain regions to be resected
- Pre-hoc validation of a brain region to be intervened upon with, e.g., DBS, RFA, FUS, radiosurgery
- Adjunctive focal pharmacotherapy for psychiatric treatment
- Scientific studies
Advantages
- Improves upon current neuromodulation methods:
- More robust mechanism of action than the direct application of ultrasound to brain for neuromodulation
- More spatially precise and increased depth of penetration than TMS or tcDCS
- Less invasive than DBS and other electrode-based methods
- Can encapsulate and deliver most any small molecule drug
- Particles amenable to large scale cGMP-compatible methods
- Safe and effective method
Publications
- Raag D. Airan, Randall A. Meyer, Nicholas P. K. Ellens, Kelly R. Rhodes, Keyvan Farahani, Martin G. Pomper, Shilpa D. Kadam, and Jordan J. Green. "Noninvasive Targeted Transcranial Neuromodulation via Focused Ultrasound Gated Drug Release from Nanoemulsions," Nano Letters, 2017.
- Airan, Raag. "Neuromodulation with nanoparticles." Science 357, no. 6350 (2017): 465-465.
News Articles
Related Links
Patents
- Published Application: WO2019036253
- Published Application: 20200368352
Similar Technologies
-
Stretchable, tunable conducting polymer hydrogels for implantable devices and tissue engineering S18-129Stretchable, tunable conducting polymer hydrogels for implantable devices and tissue engineering
-
System and device for improved ultrasound cavitation mapping S17-138System and device for improved ultrasound cavitation mapping
-
Ultrasound for Detecting and Suppressing Epileptic Seizure S18-336Ultrasound for Detecting and Suppressing Epileptic Seizure